UMDNJ Resources

Update on HIV and Hepatitis C Virus Co-Infection

References

  1. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, Yoffe B. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodefi ciency virus infection. Clin Infect Dis. 2001;33:240-247.
  2. Centers for Disease Control and Prevention [CDC]. Hepatitis C virus and HIV coinfection. 2002. Available at: http://www.cdc.gov/idu/hepatitis/hepc_and_hiv_co.htm
  3. National Institutes of Health [NIH]. Management of hepatitis C. NIH Consensus Conference Statement. June 2002. Available at http://consensus.nih.gov/2002/2002HepatitisC2002116html.htm
  4. CDC. Hepatitis surveillance report no. 59. 2004. Available at http://www.cdc.gov/hepatitis
  5. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. National HIV Prevention Conference; June 2005; Atlanta. Abstract 595.
  6. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodefi ciency virus: a crosssectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831-7.
  7. Thomas DL. Hepatitis C and human immunodefi ciency virus infection. Hepatology. 2002;36:S201-209.
  8. CDC. Treating opportunistic infections among HIV-Infected adults and adolescents. MMWR. 2004;53(RR-15):49-53.
  9. Hepatitis drug gets approval for coinfection treatment. AIDS Patient Care. 2005;19:351.
  10. Alberti A, Clumeck N, Collins S, et al. Short statement of the First European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. Journal of Hepatology. 2005;42:615-624.
  11. Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted disease clinics in
    Baltimore: an analysis of 309 sex partnerships. J Infect Dis. 1995;171:768-75.
  12. Rockstroh JK, Spengler U. HIV and hepatitis C virus co-infection. Lancet Infect Dis. 2004;4:437-44.
  13. Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis Hepatology. 2005;41:779-789.
  14. Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodefi ciency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;33:33-46.
  15. Khalili M, Proietti N. Treatment of the hepatitis C virus in patients coinfected with HIV. Gastroenterol Clin N Am. 2004;33:479-496.
  16. Chun S, Sherman KE. Treatment of hepatitis C virus/HIV coinfection. Clin Liver Dis. 2005;9:525-533.
  17. Nelson M, Matthews G, Brook MG, Main J, BHIVA Coinfection Guideline Committee. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection. HIV Medicine. 2005;6:96-106.
  18. Garcia-Samaniego J, Rodriguez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol. 2001;l96:179-83.
  19. Seeff LB. Natural history of hepatitis C. Hepatology. 1997;26:21s-28s.
  20. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study. Lancet. 2000;356:1800-5.
  21. Backus LI, Phillips BR, Boothroyd DB, et al. Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defi c Syndr. 2005;39:613-619.
  22. Miller MF, Haley C, Koziel MJ, Rowley CF. Impact of Hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis. 2005;41:713-20.
  23. National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK]. Chronic hepatitis C: current disease management. NIH Publication No.
    03-4230 2003. Available at http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm
  24. Gumber SC, Chopra S. Hepatitis C a multifaceted disease: review of extrahepatic manifestations. Ann Intern Med. 1995;123:615-620.
  25. Strader DB, Wright T, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases practice guideline: diagnosis, management, and treatment of hepatitis C. Hepatology. 2004; 39:1147-1171.
  26. U.S. Food and Drug Administration [FDA]. Hepatitis C virus encoded antigen (recombinant c33c and NS5 antigens; synthetic 5-1-1, c100, and c22
    peptides) CHIRON™ RIBA™ HCV 3.0 SIA: Strip Immunoblot Assay (SIA) for the detection of antibodies to hepatitis C virus (anti-HCV) in human
    serum or plasma. 1998. Available at: http://www.fda.gov/cber/label/hcvchir021199LB.pdf
  27. CDC. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR. 2003:52(RR-03);1-16. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5203a1.htm
  28. Sterling RK. Role of liver biopsy in the evaluation of hepatitis C virus infection in HIV coinfection. Cln Infect Dis. 2005;40:S270-5.
  29. Torriani FJ. Treatment of HCV in HIV/HCV coinfection: what are the new questions? The PRN Notebook. 2005;1024-28.
  30. Kottilil S, Polis MA, Kovacs JA. HIV infection, hepatitis C infection, and HAART: hard clinical choices. JAMA. 2004;292:243-250.
  31. Dwyer JT, Paul SM. HIV and hepatitis C co-infection. New Jersey Medicine. 2003;100:50-57.
  32. Murphy MJ, Wilcox RD. Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/ hepatitis C. Am J Med Sci. 2004;328:26-36.
  33. Carrat F, Bani-Sadr F, Stanislas P, et al. Pegylated interferon alfa-2b vs. standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA. 2004;292:2839-2848.
  34. Laguno M, Murillas J, Blanco JL, et al. Pegintron alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV HCV coinfected patients. AIDS. 2004;18:27-F36.
  35. Chung RT, Anderson J, Volberding P, et al. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV coinfected persons. New Engl J Med. 2004;351:451-9.
  36. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. New Engl J Med. 2004;351:438-50.
  37. Soriano V, Garcia-Samaniego J, Bravo R, et al. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodefi ciency virus. Clin Infect Dis. 1996;23:585-91.